Bluewater Bio appoints Dr David Lloyd Owen as Head Global Research

Bluewater Bio International, is pleased to announce it has appointed water industry expert David Lloyd Owen as Head of Global Market Research and Senior Advisor. David’s appointment comes after Bluewater Bio signs its first major contract in the Middle East and completed the installation of its first HYBACs operation in South Africa.

David Lloyd Owen is founder of Envisager Limited, an advisory service for companies, NGOs, governments and financiers active in the water and wastewater management sectors and the markets they serve. Previously, David has had extensive investment experience in the sector as an equity analyst at BNP Paribas. He was a founding Director of Ecofin Limited and a Director of Research at Delphi International, two environmental investment boutiques.

David has worked for corporate clients, institutional investors, multilateral agencies and government bodies. He sits on the advisory board of Pictet Funds (LUX) Water Fund, which currently has assets of €2.3 billion under management, and XPV Capital, a Toronto based water sector venture capital firm. David’s extensive publications include six books on the water sector, along with papers and conference appearances. He also writes a monthly column for Global Water Intelligence.

Daniel Ishag, CEO of Bluewater Bio, commented: “Bluewater Bio now operates in eight countries around the world and we are in a position to push forward commercially. David’s appointment comes at a very opportune time for the Company as we expand into new markets and, along with Water Innovate in the UK, develop and sell new products. With the recent announcement of a US$20 million contract in the Middle East, and with announcements to come in our other geographies, we feel that strengthening our research and knowledge base will help us position ourselves to excel in the market place. David’s extensive experience and excellent reputation in the sector – both commercially and financially – will put Bluewater Bio in good stead as we start to tap into new markets.”

David Lloyd Owen said: “This is a very exciting time for Bluewater Bio and I am very pleased to be joining a company that is at the forefront of wastewater treatment technologies. Having spent almost my entire career heavily involved with the sector, I feel that I can add real value to Bluewater Bio as it grows and develops its markets. I look forward to working with Daniel and the team. ”